| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 49.94▼ | 49.94▼ | 49.98▼ | 50.07▼ | 49.49▲ |
| MA10 | 49.95▼ | 50.01▼ | 50.02▼ | 49.90▲ | 49.99▼ |
| MA20 | 50.01▼ | 50.05▼ | 50.06▼ | 49.60▲ | 50.56▼ |
| MA50 | 50.05▼ | 49.98▼ | 49.89▲ | 50.13▼ | 50.91▼ |
| MA100 | 49.95▼ | 49.72▲ | 49.73▲ | 50.65▼ | 50.65▼ |
| MA200 | 49.66▲ | 49.92▲ | 50.12▼ | 50.87▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.024▼ | -0.034▼ | 0.092▲ | -0.091▼ |
| RSI | 28.935▼ | 37.135▼ | 42.797▼ | 50.523▲ | 43.360▼ |
| STOCH | 45.588 | 6.140▼ | 24.083 | 81.081▲ | 46.453 |
| WILL %R | -94.118▼ | -94.737▼ | -95.455▼ | -29.904 | -38.623 |
| CCI | -47.539 | -81.123 | -120.198▼ | 39.189 | -33.925 |
|
Sunday, April 13, 2025 05:00 PM
Vanguard Group Inc. raised its position in LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 5.3% during the 4th quarter, according to its most recent filing with the Securities and ...
|
|
Monday, April 07, 2025 05:00 PM
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report)’s share price fell 8.5% during trading on Monday .The company traded as low as $18.81 and last traded at $19.38. 351,716 shares traded ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 49.93 | 49.974 | 49.90 | 49.929 | 179,800 |
| 30/04/25 | 50.07 | 50.12 | 49.98 | 50.12 | 408,900 |
| 29/04/25 | 50.10 | 50.15 | 50.10 | 50.14 | 85,218 |
| 28/04/25 | 50.07 | 50.11 | 50.045 | 50.08 | 110,352 |
| 25/04/25 | 49.99 | 50.24 | 49.98 | 50.09 | 242,100 |
| 24/04/25 | 49.94 | 50.04 | 49.94 | 50.00 | 306,000 |
| 23/04/25 | 49.83 | 50.01 | 49.83 | 49.89 | 888,524 |
| 22/04/25 | 49.61 | 49.68 | 49.61 | 49.638 | 343,700 |
| 21/04/25 | 49.58 | 49.59 | 49.47 | 49.57 | 881,500 |
| 17/04/25 | 49.52 | 49.64 | 49.52 | 49.58 | 589,702 |
|
|
||||
|
|
||||
|
|